期刊文献+

肝癌中Ang-2的表达及其临床意义 被引量:2

EXPRESSION OF ANGIOPOIETIN-2 AND ITS CLINICAL SIGNIFICANCE ON HEPATOCELLULAR CARCINOMA
下载PDF
导出
摘要 目的探讨血管生成素2(Ang-2)与肿瘤的血管发生、入侵/转移能力和肝癌(HCC)预后之间的关系。方法采用免疫组织化学的方法检测Ang-2在肝癌、癌旁和正常肝组织中的表达。结果106例患者中,肝癌组织Ang2表达阳性的例数为63例(59.4%),Ang-2表达阳性的患者和表达阴性患者相比,很多方面有统计学差异(P<0.01),包括更低的组织学分期、门静脉侵犯(69.1%)等。Ang-2阳性表达的患者预后较差。结论肝癌Ang-2的表达和HCC的血管新生、入侵、恶性程度及疾病预后有关。 Objective To study the expression of Ang-2 in hepatocellular carcinoma (HCC), and its relationship with angiogenesis, invasion and prognosis of HCC. Methods The expression of Ang-2 in HCC was determined by means of immunohistochemistry. Results The expression of Ang-2 in HCC was significantly correlated with pathological stage and invasion of portal vein (P〈0.05). It had poor prognosis when Ang-2 expressed positive and there was tumor thrombus in portal vein ( P 〈 0.05 ). Conclusions Expression of Ang-2 could induce angiogenesis of HCC, and had obvious relation with the invasion, malignancy and prognosis of HCC.
出处 《实用临床医药杂志》 CAS 2006年第2期44-46,共3页 Journal of Clinical Medicine in Practice
基金 江苏省医学135重点人才基金
关键词 肝细胞性肝癌(HCC) 血管生成素2 预后 hepatocellular carcinoma angiopoietin-2 tumor thrombus in portal vein prognosis
  • 相关文献

参考文献11

  • 1Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease [J]. Nat Med, 1995, 1(1): 27.
  • 2Rhee J, Hoff P M. Angiogenesis inhihitors in the treatment of cancer [J ]. Expert Opin Pharmaeother, 2005, 6 ( 10 ) :1701.
  • 3Caine G J, Harris A L, Christodoulos K, et al. Analysis of combination anti-angiogenesis therapy on markers of coagula-tion, platelet activation and angiogenesis in patients with advanced cancer [J]. Cancer Lett, 2005, 219(2): 163.
  • 4Holash J, Maisonpierre P C, Compton D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF [J]. Science, 1999, 284(5422): 1994.
  • 5Mitsuhashi N, Shimizu H, Ohtsuka M, et al. Angiopoietins and Tie \ 12 expression in angiogenesis and proliferation of human hepatocellular carcinoma [J ]. Hepatology, 2003, 37(5): 1105.
  • 6Hudis C A. Clinical implications of antiangiogenie therapies[J]. Oncology (Williston Park), 2005, 19(4 Suppl 3) : 26.
  • 7Grothey A, Antiangiogenic therapy in cancer: a new era has begun [J]. Oneology (Williston Park), 2005, 19(4 Suppl3): 5.
  • 8Lenz H J. Antiangiogenic agents in cancer therapy [J]. Oncology (Williston Park), 2005, 19(4 Suppl 3) : 17.
  • 9Jain R K. Antiangiogenic therapy for cancer: Current and emerging concepts [J]. Oneology (Williston Park), 2005, 19(4 Suppl 3) : 7.
  • 10Grimmond S, Lagercrantz J, Drinkwater C, et al. Cloning and characterization of a novel human gene related to vascular endothelial growth factor [J]. Genome Res, 1996, 6 (2) :124.

同被引文献11

  • 1柳怿,李继强,刘文忠,彭延申.依那普利对大鼠肝纤维化治疗作用的实验研究[J].胃肠病学,2005,10(2):79-82. 被引量:3
  • 2涂蓉,罗建光,何冬雷,王小龙.肝硬化CT分级与肝切除术前后肝功能的相关性研究[J].海南医学院学报,2006,12(6):487-492. 被引量:4
  • 3刘厚钰.内科学[J].6版北京:人民卫生出版社,2005:448.
  • 4Rao MS.Inhibition of the renin angiotensin aldosterone system:focus on aliskiren[J].J Assoc Physicians India,2010(58):102-108.
  • 5Yoshiji H,Kuriyama S,Noguchi R,et al.Combination of interferonbeta and angiotensin-converting enzyme inhibitor,perindopril,attenuates the murine live fibrosis development[J].Liver Int,2005,25(1):153-161.
  • 6Rao M S. Inhibition of the renninangiotensin aldosterone system:fo-cus on aliskiren[J].J AssocPhysicians India,2010,(58):102-108.
  • 7Huang M L,Li X,Meng Y. Upregulation of an-giotensin-con-verting enzyme(ACE)in hepatic fibrosisby ACE inhibitors[J].Cli Exp Pharmacol Physiol,2010,(01):1-6.
  • 8Lubel J S,Herath C B,Burrel L M. Liver disease and therenin-angiotensin system:Recent Discoveries and Clinical im-plications[J].Journal of Gastroenterology and Hepatology,2008,(09):1327-1338.
  • 9Batal er R,Schwabe R F,Choi Y H. NADPH oxidase signal-transduces angiotensin II in hepatic stel ate cel s and is critical in hepaticfibrosis[J].Journal of Clinical Investigation,2003.1383-1394.
  • 10Herath C B,Warner F J,Lubel J S. Upregulation of hepati-cangiotensin-converting enzyme 2(ACE2)and angiotensin,(1-7)levels in experimental biliary fibrosis[J].Journal of Hepatology,2007,(03):387-395.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部